Acts, filings and financial milestones
Deadline for the 2026 accounts:
2026
30-08
abbreviated format · 30 days late
2025
31-12
Financial
Highest result from 2018 to 2025net €104,960 ▲14.8%
The operating result of €145,356 and the net result of €104,960 are both a record.
26-08
abbreviated format · 26 days late
2024
26-08
abbreviated format · 26 days late
2023
28-08
micro format · 28 days late
20-04
Gazette deed
Company renamed from Apotheker Fien Clarysse to FCL PharmaAmendment of the articles · Capital conversion · Registered office clause5 points ▸
Gazette deed
Company renamed from Apotheker Fien Clarysse to FCL Pharma
Amendment of the articles · Capital conversion · Registered office clause5 points ▸
- General meeting, 17-04-2023
- Amendment of the articles, mentioned 2 times in the deed
- Capital conversion, “statutair onbeschikbaar eigen vermogen” (deed in Dutch)
- Name change, FCL Pharma
- Registered office clause, “Grotendries 13C”, 3210 (deed in Dutch)
2022
19-07
micro format · 12 days before the deadline
2021
31-12
Financial
Equity above €200,000equity €215,857 ▲42.4%
With a profit in every financial year since 2018, equity grows to €215,857.
24-08
micro format · 24 days late
2020
31-12
Financial
Equity above €150,000equity €151,584 ▲50.5%
With a profit in every financial year since 2018, equity grows to €151,584.
08-10
micro format · 69 days late
2019
31-12
Financial
Equity above €100,000equity €100,693 ▲61.1%
With a profit in every financial year since 2018, equity grows to €100,693.
23-08
micro format · 23 days late
2018
29-01
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank